Current status:
Cancelled Post Market
Current status date:
2009-04-24
DIN:
00042641
Electronic product monograph is not available
Company:
ALCON CANADA INC
2665 Meadowpine Blvd
Mississauga
Ontario
Canada
L5N 8C7
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
3
Anatomical Therapeutic Chemical (ATC):
See footnote 4
S01GA51 NAPHAZOLINE, COMBINATIONS
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
ANTAZOLINE PHOSPHATE
|
0.5 %
|
NAPHAZOLINE HYDROCHLORIDE
|
0.05 %
|
ZINC SULFATE
|
0.125 %
|